BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bolcaen J, Nair S, Driver CHS, Boshomane TMG, Ebenhan T, Vandevoorde C. Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma. Pharmaceuticals (Basel) 2021;14:626. [PMID: 34209513 DOI: 10.3390/ph14070626] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Gatto L, Franceschi E, Tosoni A, Di Nunno V, Bartolini S, Brandes AA. Glioblastoma treatment slowly moves towards change: novel druggable targets and translational horizons in 2022. Expert Opin Drug Discov 2023. [PMID: 36718723 DOI: 10.1080/17460441.2023.2174097] [Reference Citation Analysis]
2 Dewdney B, Ursich L, Fletcher EV, Johns TG. Anoctamins and Calcium Signalling: An Obstacle to EGFR Targeted Therapy in Glioblastoma? Cancers (Basel) 2022;14. [PMID: 36497413 DOI: 10.3390/cancers14235932] [Reference Citation Analysis]
3 Montella L, Del Gaudio N, Bove G, Cuomo M, Buonaiuto M, Costabile D, Visconti R, Facchini G, Altucci L, Chiariotti L, Della Monica R. Looking Beyond the Glioblastoma Mask: Is Genomics the Right Path? Front Oncol 2022;12:926967. [PMID: 35875139 DOI: 10.3389/fonc.2022.926967] [Reference Citation Analysis]
4 Afonso M, Brito MA. Therapeutic Options in Neuro-Oncology. Int J Mol Sci 2022;23:5351. [PMID: 35628161 DOI: 10.3390/ijms23105351] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Rodriguez SMB, Staicu GA, Sevastre AS, Baloi C, Ciubotaru V, Dricu A, Tataranu LG. Glioblastoma Stem Cells-Useful Tools in the Battle against Cancer. Int J Mol Sci 2022;23:4602. [PMID: 35562993 DOI: 10.3390/ijms23094602] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]